This Week's News In Infectious Disease

News
Article

This week: the FDA accepts NDA for investigational antibiotic; mRNA COVID-19 vaccines update protections; counseling families on nirsevimab; and how antibiotic actions on gut microbes of patients might affect the microbiome of housemates.

Related Videos
Related Content

Living With C diff: A Unique Perspective as Patient and Provider

September 19th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

C Diff, COVID-19 Coinfection Risk Greatest in Older Women

September 15th 2023

This Week's Biggest News Stories

September 9th 2023

The News in Infectious Disease

September 1st 2023

Assessing Risk for C diff With Various Antibiotics

September 1st 2023

Living With C diff: A Unique Perspective as Patient and Provider

September 19th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

C Diff, COVID-19 Coinfection Risk Greatest in Older Women

September 15th 2023

This Week's Biggest News Stories

September 9th 2023

The News in Infectious Disease

September 1st 2023

Assessing Risk for C diff With Various Antibiotics

September 1st 2023

Living With C diff: A Unique Perspective as Patient and Provider

September 19th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

C Diff, COVID-19 Coinfection Risk Greatest in Older Women

September 15th 2023

This Week's Biggest News Stories

September 9th 2023

The News in Infectious Disease

September 1st 2023

Assessing Risk for C diff With Various Antibiotics

September 1st 2023
© 2023 MJH Life Sciences

All rights reserved.